Evidence map›Paper›PMID 37481622›Full record

ArticleScientific reports2023

Cuproptosis-related risk score based on machine learning algorithm predicts prognosis and characterizes tumor microenvironment in head and neck squamous carcinomas.

Maodong Ye, Guangping Zhang, Yongjian Lu, Shuai Ren, Yingchang Ji

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maodong Ye *Medical Cosmetic Center, First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, Guangdong, People's Republic of China. 624683069@qq.com.
Guangping Zhang *Shantou University Medical College, Shantou, 515041, Guangdong, People's Republic of China.
Yongjian Lu *Shantou University Medical College, Shantou, 515041, Guangdong, People's Republic of China.
Shuai RenMedical Cosmetic Center, First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, Guangdong, People's Republic of China. 13592821098@163.com.
Yingchang JiMedical Cosmetic Center, First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, Guangdong, People's Republic of China. jiyingchang@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cuproptosis is a recently discovered type of programmed cell death that shows significant potential in the diagnosis and treatment of cancer. It has important significance in the prognosis of HSNC. This study aims to construct a cuproptosis-related prognostic model and risk score through new data analysis methods such as machine learning algorithms for the prognosis analysis of HSNC. Protein-protein interaction network and machine learning methods were employed to identify hub genes that were used to construct a TreeGradientBoosting model for predicting overall survival. The relationship between the risk scores obtained from the model and features such as tumor microenvironment (TME) and tumor immunity was explored. The C-indexes of the TreeGradientBoosting model in the training and validation cohorts were 0.776 and 0.848, respectively. The nomogram based on risk scores and clinical features showed good performance, and distinguished the TME and immunity between high-risk and low-risk groups. The cuproptosis-associated risk score can be used to predict prognoses, TME, and tumor immunity of HNSC patients.

Indexed as

ApoptosisHead and Neck NeoplasmsTumor MicroenvironmentAlgorithmsCopperHumansMachine LearningPrognosisRisk FactorsSquamous Cell Carcinoma of Head and NeckCopper

Identifiers

PMID37481622
PMCPMC10363129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.